10 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $212M | -$104M | 0.0% | -48.0% | $9M | $209M | $49M |
| 2024 | $256M | -$189M | 0.0% | -76.5% | -$10M | $259M | $66M |
| 2023 | $285M | -$135M | 0.0% | -47.5% | -$852000 | $258M | $92M |
| 2022 | $277M | -$465M | 0.0% | -165.2% | -$55M | $226M | $122M |
| 2021 | $259M | -$129M | 0.0% | -47.4% | -$42M | $184M | $233M |
| 2020 | $187M | -$55M | 0.0% | -28.9% | -$13M | $174M | $293M |
| 2019 | $210M | -$17M | 0.0% | -8.2% | $3M | $37000 | $104M |
| 2018 | $151M | -$53M | 0.0% | -27.2% | -$25M | $47M | $40M |
| 2017 | $130M | -$20M | 0.0% | -13.1% | -$23M | $57M | $21M |
| 2016 | — | -$76M | — | — | -$34M | — | $23M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $34M | -$4M | 0.0% | -24.1% | -$6M | $204M | $36M |
| Dec '25 | $51M | -$8M | 0.0% | -12.0% | $13M | $209M | $49M |
| Sep '25 | $47M | -$73M | 0.0% | -146.6% | $2M | $261M | $44M |
| Jun '25 | $58M | -$9M | 0.0% | -22.0% | $903000 | $260M | $47M |
| Mar '25 | $56M | -$13M | 0.0% | -19.7% | -$7M | $260M | $52M |
| Dec '24 | $68M | -$16M | 0.0% | -12.2% | $3M | $259M | $66M |
| Sep '24 | $61M | -$145M | 0.0% | -243.1% | $878000 | $259M | $67M |
| Jun '24 | $64M | -$4M | 0.0% | -24.7% | $4M | $213M | $71M |
| Mar '24 | $62M | -$24M | 0.0% | -36.7% | -$18M | $258M | $98M |
| Dec '23 | $83M | -$101M | 0.0% | -124.6% | $3M | $258M | $92M |
| Sep '23 | $73M | -$24M | 0.0% | -28.3% | $1M | $287M | $90M |
| Jun '23 | $71M | -$24M | 0.0% | -34.4% | $6M | $287M | $92M |
| Mar '23 | $59M | $14M | 0.0% | 20.7% | -$10M | $256M | $139M |
| Dec '22 | $77M | -$378M | 0.0% | -499.2% | -$13M | $226M | $122M |
| Sep '22 | $67M | $6M | 0.0% | 17.1% | -$15M | — | $139M |
| Jun '22 | $69M | -$126M | 0.0% | -176.6% | -$7M | — | $157M |
| Mar '22 | $64M | $33M | 0.0% | 55.7% | -$20M | — | $208M |
| Dec '21 | $87M | -$12M | 0.0% | -18.9% | -$2M | $184M | $233M |
| Sep '21 | $62M | -$45M | 0.0% | -64.1% | -$11M | — | $237M |
| Jun '21 | $57M | -$47M | 0.0% | -77.9% | -$15M | — | $251M |
How the market has priced CDLX against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Cardlytics, Inc.'s revenue has grown 2.6% per year. These are computed facts, not advice.
As of FY2025, Cardlytics, Inc. reported $209M of total debt against $49M of cash; operating income covered interest expense 9.6×.
In FY2025, gross margin was —, operating margin -48.0%, and net margin -49.0%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.